Sequent Scientific Ltd.

₹N/A

N/A

N/A - close price

BSE: SEQUENT

NSE: SEQUENT

Industry: Pharmaceuticals & Drugs

House: Sequent

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 0.87Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.87Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 9.30Good: 20

❌

Current Ratio

Bad: 1Current: 1.68Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 5.44Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.39Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.87Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.87Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 9.30Good: 20

❌

Current Ratio

Bad: 1Current: 1.68Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 5.44Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.39Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	333.21	345.97	329.36	361.20	390.21
Expenditure+	341.45	330.84	307.11	328.93	348.26
Other Income+	0.79	1.65	4.52	4.00	2.68
Operating Profit	-8.24	15.13	22.25	32.27	41.95
Interest	10.48	12.58	12.58	12.44	16.38
Depreciation and Amortization	14.24	15.36	15.46	16.48	16.25
Profit Before Tax	-55.68	-3.09	1.49	2.64	12.00
Tax+	-21.00	3.79	-9.18	1.36	2.94
Net Profit	-34.68	-6.88	10.68	1.27	9.06

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	13616.15	14128.16	14209.09	13697.31	15513.70
Operational Expenses+	11516.77	13034.31	14089.54	13083.17	13925.04
Operating Profit	2099.38	1093.85	119.55	614.14	1588.66
Other Income	104.95	108.60	63.90	109.57	176.18
OPM %	15.42	7.74	0.84	4.48	10.24
Depreciation and Amortisation	505.98	515.41	556.93	615.40	664.51
Interest	243.83	157.74	355.17	480.86	607.51
Profit Before Tax	1366.29	529.30	-1376.58	-546.46	443.06
Tax	292.39	201.96	-153.57	-244.99	118.77
Net Profit	954.42	409.55	-1211.59	-358.69	218.78

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	14430.11	14865.68	14837.61	15310.53	15720.88
Liabilities+	14430.11	14865.68	14837.61	15310.53	15720.88

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	1147.54	305.95	168.08	305.95	833.62
Cash from Investing Activity	96.48	-955.66	-649.58	-59.20	-247.78
Cash from Financing Activity	-1387.54	672.57	322.28	-14.39	-607.34
Net Cash Flow	-143.52	22.86	-159.22	232.36	-21.50
Opening Cash & Cash Equivalents	680.96	537.44	574.96	415.74	648.10
Closing Cash & Cash Equivalents	537.44	574.96	415.74	648.10	626.60

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	52.33	52.61	52.61	52.61	52.76	52.78	52.79	52.79	52.79	52.79
Public+	47.67	47.39	47.39	47.39	47.24	47.22	47.21	47.21	47.21	47.21
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	144085	147320	158152	162574	154603	163693	166593	172853	184521	187474

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	13616.15	14128.16	14209.09	13697.31	15513.70
Operational Expenses+	11516.77	13034.31	14089.54	13083.17	13925.04
Operating Profit	2099.38	1093.85	119.55	614.14	1588.66
Other Income	104.95	108.60	63.90	109.57	176.18
OPM %	15.42	7.74	0.84	4.48	10.24
Depreciation and Amortisation	505.98	515.41	556.93	615.40	664.51
Interest	243.83	157.74	355.17	480.86	607.51
Profit Before Tax	1366.29	529.30	-1376.58	-546.46	443.06
Tax	292.39	201.96	-153.57	-244.99	118.77
Net Profit	954.42	409.55	-1211.59	-358.69	218.78

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	1147.54	305.95	168.08	305.95	833.62
Cash from Investing Activity	96.48	-955.66	-649.58	-59.20	-247.78
Cash from Financing Activity	-1387.54	672.57	322.28	-14.39	-607.34
Net Cash Flow	-143.52	22.86	-159.22	232.36	-21.50
Opening Cash & Cash Equivalents	680.96	537.44	574.96	415.74	648.10
Closing Cash & Cash Equivalents	537.44	574.96	415.74	648.10	626.60

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	333.21	345.97	329.36	361.20	390.21
Expenditure+	341.45	330.84	307.11	328.93	348.26
Other Income+	0.79	1.65	4.52	4.00	2.68
Operating Profit	-8.24	15.13	22.25	32.27	41.95
Interest	10.48	12.58	12.58	12.44	16.38
Depreciation and Amortization	14.24	15.36	15.46	16.48	16.25
Profit Before Tax	-55.68	-3.09	1.49	2.64	12.00
Tax+	-21.00	3.79	-9.18	1.36	2.94
Net Profit	-34.68	-6.88	10.68	1.27	9.06

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	52.33	52.61	52.61	52.61	52.76	52.78	52.79	52.79	52.79	52.79
Public+	47.67	47.39	47.39	47.39	47.24	47.22	47.21	47.21	47.21	47.21
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	144085	147320	158152	162574	154603	163693	166593	172853	184521	187474

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	14430.11	14865.68	14837.61	15310.53	15720.88
Liabilities+	14430.11	14865.68	14837.61	15310.53	15720.88

Ratios

Reported EPS

Bad: 2Current: 0.87Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.87Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 9.30Good: 20

❌

Current Ratio

Bad: 1Current: 1.68Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 5.44Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.39Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.87Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.87Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 9.30Good: 20

❌

Current Ratio

Bad: 1Current: 1.68Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 5.44Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.39Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Sequent Scientific Ltd.

₹N/A

N/A

N/A - close price

BSE: SEQUENT

NSE: SEQUENT

Industry: Pharmaceuticals & Drugs

House: Sequent

Overview